Dr Reddy’s Laboratories acquires 6.46% stake in Edity Therapeutics for $2 million
The company raised $11.1 million of Series A1 venture funding from Dr. Reddy’s Laboratories and OurCrowdon. The funds will be used to further develop its technology platform which includes performing pre-clinical studies for safety and efficacy evaluation, securing intellectual property through patent filings and exploring licensing opportunities, collaborations and market entry strategies to optimize the […]
Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines
The Series B round has been led by Sanofi Ventures with participation from new investor Bpifrance (through its InnoBio 2 fund), and existing investors Khosla Ventures and Seventure Partners. The funding is expected to generate proof of concept clinical data in patients.
TOLREMO therapeutics Completes $39 Million Series A Financing Round with Strategic Investment from Pierre Fabre Invest
Tolremo has completed its Series A financing, bringing the total amount raised to $39 million (CHF 34.1 million). BioMedPartners AG led the round with participation from a new investor, Pierre Fabre Invest, as well as existing investors. The Series A round will be used to fund a Phase I trial for its lead candidate in […]
Acorai starts Phase I clinical trial in Europe and the US
Acorai has announced the initiation of a global clinical trial with the enrollment of its first patient in London, UK. Acorai was designated as a breakthrough device by the US FDA in August 2023 and they aim to submit their heart monitor for regulatory approval to the FDA and CE-marking in 2024.
Life-science consultancy Advice Connect Inspire, LLC reaches €500M raised by portfolio companies
CAMBRIDGE, MA, USA, May 29, 2023/EINPresswire.com/ — With a portfolio of over 40 companies, Cambridge-based Advise Connect Inspire, LLC (ACI) is committed to scaling startups and developing leaders who shape the future of healthcare. ACI launched its flagship program, Gold Track, three years ago and recently passed €500M raised by its portfolio companies. Notably, therapeutics […]
GoldTrack Graduate Launches Digital Pre-Analytical Monitoring System in Ten Countries in Europe
Exciting news from of our portfolio companies Smart4Diagnostics GmbH, whose digital pre-analytical monitoring system is live in ten countries in Europe. SD4X was a graduate of our #GoldTrack program; we look forward to their tech scaling globally!
CureSight™ Wins 2023 MedTech Breakthrough Award
Big congratulations to NovaSight for winning this prestigious award! On a path to advance treatment for amblyopia, NovaSight was part of our #GoldTrack program where they received mentoring and strategic support to further their mission.
Portfolio Company Proxygen Lands a Collaboration Deal with Merck
Hearty congrats to one of our portfolio companies, Proxygen, for landing a collaboration deal with Merck! This multi-year agreement is set to further the development of molecular glue degraders against multiple therapeutic targets.
Sensible Biotechnologies Lands a Partnership Deal with Ginkgo Bioworks, Inc.
Congratulations to Sensible Biotechnologies for landing a partnership deal with Ginkgo Bioworks, Inc.! Sensible Bio is one of the companies we are currently supporting through the #Goldtrack program. Looking forward to building more successes with you!
NU-RISE Has Secured a €3.35M Seed Round to Help Bring Safety and More Accurate Radiation Cancer Treatments
Always brings a smile to our faces when we hear success stories from our alumni companies!
